These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16043141)

  • 1. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene.
    Bayat A; Walter JM; Bock O; Mrowietz U; Ollier WE; Ferguson MW
    Br J Plast Surg; 2005 Oct; 58(7):914-21. PubMed ID: 16043141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid denaturing high-performance liquid chromatography (DHPLC) for mutation scanning of the transforming growth factor beta3 gene using a novel proof-reading polymerase.
    Bayat A; Walter JM; Lamb H; Ferguson MW; Ollier WE
    Eur J Immunogenet; 2003 Oct; 30(5):335-40. PubMed ID: 14641540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease.
    Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
    Exp Dermatol; 2004 Feb; 13(2):120-4. PubMed ID: 15009106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of keloid scarring.
    Shih B; Bayat A
    Arch Dermatol Res; 2010 Jul; 302(5):319-39. PubMed ID: 20130896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of CDC2L1 gene mutations in keloid tissue.
    Zhang G; Jiang J; Luo S; Tang S; Liang J; Yao P
    Clin Exp Dermatol; 2012 Apr; 37(3):277-83. PubMed ID: 22188294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta (TGFbeta) and keloid disease.
    Jagadeesan J; Bayat A
    Int J Surg; 2007 Aug; 5(4):278-85. PubMed ID: 17660136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms.
    Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
    Br J Plast Surg; 2002 Jun; 55(4):283-6. PubMed ID: 12160532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
    Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations of dystrophin gene in DMD patients detected by rapid scanning in biplex exons DHPLC analysis.
    Muscarella LA; Piemontese MR; Barbano R; Fazio A; Guarnieri V; Quattrone A; Zelante L
    Biomol Eng; 2007 Jun; 24(2):231-6. PubMed ID: 17145200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between RUNX3 gene mutation and keloid].
    Zhang G; Jiang JJ; Luo SJ; Tang SM; Liang J; Yu Q
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 May; 24(3):224-7. PubMed ID: 18717361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes.
    Rampazzo A; Beffagna G; Nava A; Occhi G; Bauce B; Noiato M; Basso C; Frigo G; Thiene G; Towbin J; Danieli GA
    Eur J Hum Genet; 2003 Jan; 11(1):69-76. PubMed ID: 12529708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hunchback sequence binding protein suppresses mouse TGF-beta3 promoter in vitro.
    Yamazaki K; Crowe DL; Shuler CF
    Biochem Biophys Res Commun; 2006 Aug; 346(3):802-9. PubMed ID: 16781676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
    Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
    Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of exonic sulfotransferase 4A1 mutations in controls and schizophrenia cases.
    Lewis AG; Minchin RF
    Psychiatr Genet; 2009 Feb; 19(1):53-5. PubMed ID: 19125109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels.
    Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
    Plast Reconstr Surg; 2003 Feb; 111(2):535-43; discussion 544-6. PubMed ID: 12560674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of transforming growth factor-beta1 gene polymorphism with familial vesicoureteral reflux.
    Kuroda S; Solari V; Puri P
    J Urol; 2007 Oct; 178(4 Pt 2):1650-3. PubMed ID: 17707032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on p53 gene mutation in keloid fibroblasts].
    Liu W; Jiang YH; Li YL; Lin ZH; Jiang H; Tan Q; Zhang JL; Wang ZM
    Zhonghua Shao Shang Za Zhi; 2004 Apr; 20(2):85-7. PubMed ID: 15312469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.